FridayApr 17, 2026 2:10 pm

QualityStocksNewsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Deploys AI, Thermal Imaging to Redefine Rail Safety

Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the industry,” reads a recent article. “Rail Vision’s AI-powered electro-optical sensor systems are designed to address key railway safety challenges by integrating wide-field and narrow-field electro-optic cameras to provide a complete ‘safety envelope’ around the train. The company’s solutions include the use of thermal cameras that…

Continue Reading

FridayApr 17, 2026 1:19 pm

QualityStocksNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. By inhibiting PP2A, the compound stimulates cell-cycle progression and interferes with DNA repair in cancer cells, potentially making tumors more responsive to chemotherapy and immunotherapy. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with significant unmet medical need, including ovarian clear…

Continue Reading

FridayApr 17, 2026 12:37 pm

QualityStocksNewsBreaks – Why Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is ‘One to Watch’

Artificial intelligence-powered cardiovascular medicine company Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its focus on cardiovascular disease prevention, detection, and management. The publication reads, “The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators… At the core of its strategy is the integration of epigenetics, genetics, and artificial intelligence to generate insights from a patient’s molecular profile. By analyzing both inherited predisposition and changes influenced by lifestyle and environment, the company’s platform is designed to provide a more complete view of cardiovascular disease.”…

Continue Reading

FridayApr 17, 2026 12:35 pm

QualityStocksNewsBreaks – Suntex Enterprises Inc. (OTC: SNTX) Reports Restructuring Completion and Simplified Capital Structure

Suntex Enterprises (OTC: SNTX) announced the filing of its annual financial statements, highlighting a completed operational restructuring and simplified capital structure with no outstanding debt or convertible instruments. The company also confirmed submission of a corporate action to FINRA seeking approval for a shareholder dividend tied to a diversified portfolio of operating businesses, as Suntex advances a strategy focused on scaling its subsidiaries through organic growth and acquisitions while targeting approximately $100 million in annual revenue and evaluating potential uplisting opportunities. To view the full press release, visit https://ibn.fm/pFJV1 About Suntex Enterprises, Inc. (OTC: SNTX) Suntex Enterprises, Inc. is a diversified…

Continue Reading

FridayApr 17, 2026 9:10 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Closes $10 Million Public Offering to Advance Cardiac Technology Commercialization

HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common stock, generating gross proceeds of $10 million before expenses, with the transaction completed on April 16, 2026. The offering, supported by key stakeholders including ClearCardio(TM), company leadership and institutional investors, will fund commercialization of HeartBeam’s FDA-cleared 12-lead synthesized ECG system, further development of its extended-wear patch and heart attack detection technologies, expansion of AI capabilities and general corporate purposes To view the full press release, visit https://ibn.fm/9iNYY About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the…

Continue Reading

ThursdayApr 16, 2026 12:05 pm

QualityStocksNewsBreaks – Roth Capital Partners Appoints Seth Appel Head of ATM and Equity Alternatives Banking

Roth Capital Partners announced the appointment of Seth Appel as head of ATM and equity alternatives banking, bringing more than 30 years of capital markets experience to expand the firm’s equity capital markets capabilities and support growth companies in raising capital. In connection with the appointment, Appel will also serve as co-chief investment officer of the RoHo Capital Opportunities Fund, a joint venture with Horizon Technology Finance Corporation (NASDAQ: HRZN), focused on providing debt financing solutions to small- and micro-cap public companies. To view the full press release, visit https://ibn.fm/Mxqo7 About ROTH ROTH is a relationship-driven investment bank focused on…

Continue Reading

ThursdayApr 16, 2026 10:30 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Quantum-Ready HPC GPU Network in New York and Philadelphia 

Datavault AI (NASDAQ: DVLT) a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced that the first sites of its quantum-ready high-performance computing GPU network are now live in New York and Philadelphia, with full commercial availability of its planned 48,000-GPU fleet expected in Q3 2026. The network, designed to operate outside the hyperscaler supply chain, will scale across 1,000 micro-edge sites in more than 100 U.S. cities and support low-latency AI inference, data tokenization and monetization through the company’s IDE(R), DataValue(R) and DataScore(R) platforms, positioning it as an alternative source of secure enterprise AI compute capacity amid ongoing GPU supply constraints. To view…

Continue Reading

ThursdayApr 16, 2026 9:48 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports FY 2025 Net Income of $249 Million 

Oncotelic Therapeutics (OTCQB: OTLC), a clinical-stage biopharmaceutical company focused on orphan oncology and advanced drug platforms, reported financial results for the fiscal year ended Dec. 31, 2025, with net income of approximately $249.0 million compared to a net loss of $4.8 million in FY 2024, primarily driven by a non-cash gain of approximately $365.4 million from the increased valuation of its GMP Biotechnology joint venture, partially offset by a deferred tax provision of $111.6 million. To view the full press release, visit https://ibn.fm/imTdU About Oncotelic Oncotelic (f/k/a Mateon Therapeutics, Inc.), was formed in the State of New York in 1988 as OXiGENE, Inc., was reincorporated in the State…

Continue Reading

ThursdayApr 16, 2026 9:30 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Advances Commercialization With Robotics Supply Agreement

Nightfood Holdings (OTCQB: NGTF), operating through its TechForce Robotics subsidiary, announced the execution of a strategic supply agreement with NUWA Robotics Corp. and Foxconn, marking its transition from development and pilot programs to commercial deployment of robotic platforms. The agreement establishes a framework for engineering, manufacturing and commercialization, with TechForce retaining exclusive intellectual property ownership while leveraging NUWA’s system integration expertise and Foxconn’s global manufacturing capabilities to scale production and support growing demand for its Robotics-as-a-Service model. To view the full press release, visit https://ibn.fm/Zy1Kg About TechForce Robotics TechForce Robotics, Inc., a whollyowned subsidiary of the Company, is an AI-Enhanced…

Continue Reading

WednesdayApr 15, 2026 3:14 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Targets Growth in Defense Sector with Strategic Appointment

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) recently announced the appointment of Matt McCrann as CEO of its U.S. subsidiary, a move that signals a focused push into the world’s largest defense market. “McCrann previously served as CEO of the U.S. subsidiary of DroneShield, where he led operational expansion during a period of revenue growth and increasing federal adoption,” an article discussing this reads. “McCrann’s mandate is operational rather than symbolic. He will lead SPARC AI’s North American expansion, build out U.S. infrastructure and teams, advance field evaluations and pilot…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered